skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Download Q3 Hot Picks: Our most popular quarterly news and insights

Now you can tap into the Pink Sheet articles that subscribers are accessing most. Keep up with the policy, regulatory, and compliance news and insight that your industry peers are paying attention to with Pink Sheet’s Hot Picks article pack.


Your free Pink Sheet Hot Picks pack includes the articles:

Novartis’ Zolgensma Had Manipulated Data In Application, US FDA Says 
New Age Thinking: US FDA’s Temple Sees Third Era Of Drug Development 
US FDA’s Office Of New Drugs Reorganization Approved, But Not Happening Overnight 
AbbVie And Allergan: Five Big Review Questions To Worry About 
FDA’s Withdrawn Reg On Data Fraud Hangs Over Zolgensma Incident 
How Risky Is Amgen’s At-Risk Launch Of Herceptin, Avastin Biosimilars?


Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: